Immunogenicity of Adjuvanted Psoralen-Inactivated SARS-CoV-2 Vaccines and SARS-CoV-2 Spike Protein DNA Vaccines in BALB/c Mice

Immunogenicity of Adjuvanted Psoralen-Inactivated SARS-CoV-2 Vaccines and SARS-CoV-2 Spike Protein DNA Vaccines in BALB/c Mice

The development of a safe and effective vaccine to protect against COVID-19 is a global priority due to the current high SARS-CoV-2 infection rate. Currently, there are over 160 SARS-CoV-2 vaccine candidates at the clinical or pre-clinical stages of development. Of these, there are only three whole-...

Full description

Bibliographic Details
Main Authors: Appavu K. Sundaram, Daniel Ewing, Zhaodong Liang, Vihasi Jani, Ying Cheng, Peifang Sun, Kanakatte Raviprakash, Shuenn-Jue Wu, Nikolai Petrovsky, Gabriel Defang, Maya Williams, Kevin R. Porter
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Pathogens
Subjects:
SARS-CoV-2
COVID-19
psoralen-inactivated SARS-CoV-2 vaccine
anti-SARS-CoV-2-neutralizing antibodies
conformational epitopes of surface antigens
4′-aminomethyl-4,5′,8-trimethylpsoralen (AMT)
Online Access:https://www.mdpi.com/2076-0817/10/5/626

Internet

https://www.mdpi.com/2076-0817/10/5/626

Similar Items